★ Introduction of RMSC-2012

Regenerative medicine and stem cell constitute a huge industry of medical technology and services, which is led to the Multi-disciplinary Cross Action and cooperation, such as Basic Sciences, Novel Technologies, and Clinical Translations. It has a perspective to form a biotechnology industry chain with the development of regenerative medicine industry as the center, which will be one of the high-tech industries with the huge potential in 21st century. RMSC-2012 will offers excellent opportunities for participants to get the lasted research progress, to seek cooperation and to gain the new ideas through the communication with international experts.

★ Programmed Chapters at a Glance

★ Highlights of the Conference

Represent 100+ World's most Respected Research and Commercial Institutions in RMSC R&D
Arrange 200+ Presentations in Sciences, Technologies and Business Development from World Leading Scientists and Industrial Executives
Demonstrate 80+ Scientific and Technological Posters
Attract 300+ Participants
Create a Harmony Environment for One-to-One Meetings with Key Decision Makers
Kinds of Dream Tours to Ancient China

★ Past Event

RMSC-2011 successfully held in Beijing International Convention Center on November 11-13, 2011. Totally, there were nearly 200 participants from more than 30 countries and areas have attended the RMSC-2011.Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing RMSC-2012 which would be better and more successful than RMSC-2011.more...

★ Keynote Speakers for RMSC-2012

	Dr. William James, Professor & Vice-Chancellor, University of Oxford, UK		Dr. Jonathan M. W. Slack, Professor and Director, Stem Cell Institute, University of Minnesota, USA (EMBO Member)
	Dr. Lukas Utiger, COO, Lonza Bioscience, USA		Dr. John Yu, Distinguished Research Fellow, Academia Sinica, Taiwan
	Dr. Nagy Habib, Professor of Hepatobiliary Surgery, Imperial College London, UK

★ Renowned Speakers for RMSC-2012

Dr. Dawn Driscoll, Principal, DCi Biotech, USA	Dr. Chris N. Airriess, Chief Operating Officer, California Stem Cell, USA	Dr. Michael F.G. Schmidt, Professor, Freie University Berlin, Germany

Dr. Antonio Apicella, Full Professor and Chair, Materials Science and Technology, Second University of Naples, Italy	Dr. Charles Sherwood, President & CEO, Anika Therapeutics, Inc., USA	Dr. Peter Frey, Professor and Head of Pediatric Urology, University Hospital Lausanne (CHUV), Switzerland

Dr. Franz E. Weber, Professor, University of Zurich, Switzerland	Dr. Daniel G. Miller, President & CEO & Director , Excorp Medical, Inc., USA	Dr. Wolf-Dieter Grimm, Professor, University of Witten/Herdecke, Germany

Dr. Prasad Yarlagadda, Professor, Queensland University of Techonology, Australia